Ellicott City, MD, United States of America

Susan K Keay

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 96(Granted Patents)


Company Filing History:


Years Active: 1999-2015

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Susan K Keay: Innovator in Antiproliferative Research

Introduction

Susan K Keay is a prominent inventor based in Ellicott City, MD (US). She has made significant contributions to the field of medical research, particularly in the development of antiproliferative factors. With a total of 9 patents to her name, her work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among her latest patents is the "Antiproliferative factor and methods of use," which discloses a novel antiproliferative factor comprising a glycopeptide. This innovative factor is specifically associated with the bladder and includes compositions, diagnostic kits, and reagents. These methods are aimed at identifying and treating interstitial cystitis and cancer. Another notable patent is "Derivatives of APF and methods of use," which also focuses on a glycopeptide associated with the bladder, providing further advancements in the treatment of related conditions.

Career Highlights

Throughout her career, Susan has worked with esteemed organizations such as the University System of Maryland and the United States Government as represented by the Department of Veterans Affairs. Her research has been pivotal in advancing the understanding and treatment of bladder-related conditions.

Collaborations

Susan has collaborated with notable colleagues, including John W Warren and Michael K Hise. These partnerships have contributed to her innovative research and the successful development of her patents.

Conclusion

Susan K Keay's work in the field of antiproliferative research showcases her dedication to advancing medical science. Her patents reflect her innovative spirit and commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…